Sep 20, 2022Syngenta, Bioceres Crop Solutions collaborate on seed treatments
Customers seeking cutting-edge biological seed treatment solutions will benefit from a global commercial and research and development collaboration between
Syngenta Crop Protection’s Seedcare business and Bioceres Crop Solutions, a leader in biological crop productivity solutions, have a global commercial and research collaboration.
The collaboration between Bioceres and Syngenta builds on a successful commercial partnership of more than 20 years in Argentina. Under the agreement, Syngenta Seedcare will become the exclusive global commercialization distributor for Bioceres’ biological seed treatment solutions, except in Argentina where they will continue to collaborate under the existing framework. Under the long-term research and development collaboration, the companies will jointly undertake the development of new products while accelerating the registration of products already in the pipeline.
“The agreement with Bioceres furthers our strategy to provide growers with more complementary choices to manage pest resistance and improve crop health,” Jonathan Brown, global head of Syngenta Seedcare, said in a news release. “We draw strengths from our longstanding relationship with Bioceres and are fully committed to providing growers with more sustainable innovations to further improve seed health.”
“This announcement shows the value of our commercial offerings and R&D capabilities, and greatly expands and accelerates our ability to reach more growers through the global reach of Syngenta Seedcare,” Bioceres CEO Federico Trucco said in the release. “Biological products play an important role in offering growers new solutions to increase crop yields while reducing agriculture’s environmental footprint. We believe this collaboration with Syngenta will allow us both to advance those goals more rapidly in a time of significant global need for new solutions.”
Syngenta Seedcare and Bioceres will expand their cooperation in key markets such as Brazil and China, as well as in other regions around the world. Implementation of the agreement will be subject to regulatory clearances.
Through the agreement, Bioceres will retain global rights to use its biologicals solutions on HB4 crops, which have been modified to better withstand drought events. The portfolio of Marrone Bio Innovations, recently acquired by Bioceres and commercialized by ProFarm Group, one of Bioceres’ main subsidiaries, is also outside the scope of the current agreement.